DR. YUN SUN M.D. NPI 1316913098

NPI Details

DR. Yun Sun, M.D. is a pain medicine pain medicine in Greensboro, NC with 37 years of experience. The provider is pain Medicine is a primary medical specialty based on a distinct body of knowledge and a well-defined scope of clinical practice that is founded on science, research and education. It is concerned with the study of pain, the prevention of pain, and the evaluation, treatment, and rehabilitation of persons in pain. A comprehensive evaluation incorporates the physical, psychological, cognitive and socio-cultural contributions to pain. The treatment protocol may include pharmacological, invasive, behavioral, cognitive, rehabilitative and complementary strategies provided in a concurrent focused and patient specific manner. The pain medicine physician often serves the patient as a frontline physician regarding their pain, but also may serve as a consultant to other physicians, direct an interdisciplinary/multidisciplinary treatment team, conduct research, or advocate for the patient's pain care with public and private agencies. The Pain Medicine physician may work in variety of settings including office, clinic, hospital, university, or governmental/public agencies. DR. Yun Sun, M.D. NPI is 1316913098. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

3402 BATTLEGROUND AVE
GREENSBORO, NC
ZIP 27410-404
Phone: (336) 883-0029

The NPI 1316913098 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Testing for presence of drug, by chemistry analyzers (HCPCS:80307)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Vitamin d-3 level (HCPCS:82306)
• Hemoglobin a1c level (HCPCS:83036)
• Parathormone (parathyroid hormone) level (HCPCS:83970)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Thyroid hormone, t3 measurement, total (HCPCS:84480)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (HCPCS:G0481)
• Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit (HCPCS:G0439)
• Uric acid level, blood (HCPCS:84550)
• Rheumatoid factor level (HCPCS:86431)
• Annual alcohol misuse screening, 15 minutes (HCPCS:G0442)
• Influenza vaccine, quadrivalent derived from cell cultures (HCPCS:90756)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus (HCPCS:87426)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
• Urinalysis, manual test (HCPCS:81002)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
• Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes (HCPCS:G0446)
• Smoking and tobacco use intensive counseling, 4-10 minutes (HCPCS:99406)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
• Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
• Ultrasound study of arm or leg veins with compression and maneuvers (HCPCS:93970)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Ultrasound of both sides of head and neck blood flow (HCPCS:93880)
• Ultrasound study of arm and leg arteries (HCPCS:93922)
• Ultrasound of leg arteries or artery grafts (HCPCS:93925)
• New patient office or other outpatient visit, 15-29 minutes (HCPCS:99202)
• Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (HCPCS:G0480)
• Annual depression screening, 15 minutes (HCPCS:G0444)
• Hepatitis c antibody measurement (HCPCS:86803)
• Colonoscopy (HCPCS:NAN13)

The enumeration date for this NPI number is 2/23/2006 and was last updated on 12/8/2021.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.